# Biotech Independent Audit Report

**Audit date:** 2026-09-29  
**Repository examined:** `-Live-Pharmacovigilance-Evidence-And-Drug-Safety-Intelligence-Pipeline-v1-AI-Biotech-Core-Task-1`  
**Scope limit:** This clone contains one pharmacovigilance evidence pipeline. It does not contain the four candidate capability repositories or submissions described in the team brief. Findings below concern this repository only; absence here is not a judgment on work held elsewhere.

## Executive Finding

The pharmacovigilance pipeline has implemented retrieval, normalization, evidence validation, local JSON persistence, duplicate suppression, monitoring, and error-handling modules. On the checked-out baseline, `pytest -q` did not collect tests because `src.*` imports could not resolve. A minimal `src` package path bridge was added; after that change, the complete suite executed with **47 passed**. The `pytest.ini` test path was aligned with the actual root-level test layout, yielding a clean run with no warnings. A CLI empty-input run also started successfully and exited through the expected validation path without making a network request.

This proves a local testable capability, not live OpenFDA retrieval, deployment, nor integration into the wider Biotech system. No live API call was made during this audit. The other three capability streams cannot be independently classified from this clone.

## Capability Status

| Capability                                           | Repository evidence                                                                                                                             | Status                                                                                                               |
| ---------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------- |
| Drug Safety Evidence Integration (pharmacovigilance) | Root-level connector, normalization, schema, storage, monitoring, error handling, CLI, and tests; 47 tests executed after package import repair | IMPLEMENTED; TESTED; REPRODUCIBLE locally; INTEGRATION READY: BLOCKED pending shared contract and other repositories |
| Formulation & Stability Evidence Intelligence        | No corresponding implementation or submission in this repository                                                                                | BLOCKED: capability repository/submission unavailable for audit                                                      |
| TB Drug-Discovery Candidate Intelligence             | No corresponding implementation or submission in this repository                                                                                | BLOCKED: capability repository/submission unavailable for audit                                                      |
| Biosimilarity & Preclinical Evidence QC              | No corresponding implementation or submission in this repository                                                                                | BLOCKED: capability repository/submission unavailable for audit                                                      |

The brief itself names the three absent streams but is not implementation evidence. They are not classified as DOCUMENTED ONLY on that basis.

## Verified Execution Path

Repository root -> `app.py` -> interactive drug name -> `openfda_connector.search_drug` -> `normalize_evidence.normalize_record` -> `evidence_schema.validate_evidence` -> `evidence_store.add_evidence` -> `evidence_output.json`; operational events are sent through `monitoring.log_event`, and uncaught application exceptions pass through `error_handler.handle_application_error`.

Core review files (maximum three):

1. `openfda_connector.py` - external retrieval boundary.
2. `normalize_evidence.py` - raw record transformation and conservative entity resolution.
3. `evidence_schema.py` - output record structure and validation.

The CLI/storage integration is implemented by `app.py` and `evidence_store.py`; see the capability packet for exact contract details.

## Evidence and Validation Findings

- **Executable tests:** `c:/python313/python.exe -m pytest -q` after adding `src/__init__.py` and correcting `pytest.ini`: 47 passed, no warnings. The initial baseline attempt failed collection in all eight test modules with `ModuleNotFoundError: No module named 'src'`.
- **Runtime:** `printf '\n' | c:/python313/python.exe app.py` displayed the search prompt, rejected empty input, logged `EMPTY_DRUG_INPUT`, and did not call the external API.
- **Live retrieval:** Not run in this audit. Network/API behavior is only covered by mocked connector tests; the historic runtime claims in `FINAL_DELIVERABLE_REPORT.md` were not independently re-executed.
- **Stored sample:** `evidence_output.json` contains records with OpenFDA/FAERS labels and retrieval metadata. Their source authenticity and synthetic/real-world status were not independently established. Treat as unverified sample data, not fresh audit evidence.
- **Schema:** Validation requires evidence ID, source, evidence type, retrieval time, source URL, schema version, required provenance keys, allowed entity-resolution status, and `REPORTED_ASSOCIATION`. It does not enforce declared field types or validate all optional/nullable fields.
- **Provenance:** Source system, dataset, retrieval method, transformation, record reference, URL, and retrieval timestamp are represented. The output does not explicitly label the dataset as synthetic vs real; provenance content alone does not verify origin.
- **Duplicates:** Storage blocks duplicates by source record ID, or by a deterministic content fingerprint when the source ID is absent, including duplicates in one batch. Conflicting records sharing one source ID are silently treated as duplicates rather than surfaced as conflicts.
- **Determinism:** Entity matching and fallback content fingerprinting are deterministic for identical inputs. Retrieval timestamps and API results vary by run; exact whole-output reproducibility from live inputs is therefore not established.
- **Failure/input cases:** Automated tests exercise malformed response shape, network failure (mock), invalid evidence, empty results, duplicate and repeat ingestion. Empty CLI input was executed. Explicit tests for missing required raw fields, conflicting same-ID records, malformed JSON bytes, or an empty persisted dataset were not found in the inspected suite.
- **Scientific boundary:** Evidence is represented as `REPORTED_ASSOCIATION`; the implementation does not establish causality or make clinical, safety, efficacy, approval, or treatment decisions.

## Change Made During Audit

Added `src/__init__.py` to expose the existing root-level modules under the `src.*` imports already used by the application and test suite, and aligned `pytest.ini` to collect root-level tests without fallback warnings. No domain logic or sample evidence was changed.

## Integration Assessment

The working local interface is a Python `EvidenceRecord` dataclass serialized to a JSON object, with `validate_evidence(record) -> (bool, list[str])` and `add_evidence(list[dict]) -> int`. This is a candidate adapter boundary, not an agreed cross-capability schema. Do not merge or replatform other capabilities until their repositories, schemas, provenance semantics, and owners are available for comparison.

See [BIOTECH_INTEGRATION_READINESS.md](BIOTECH_INTEGRATION_READINESS.md), [BIOTECH_GAP_REGISTER.md](BIOTECH_GAP_REGISTER.md), [BIOTECH_DEPENDENCY_REGISTER.md](BIOTECH_DEPENDENCY_REGISTER.md), [BIOTECH_CONVERGENCE_MAP.md](BIOTECH_CONVERGENCE_MAP.md), and [review_packets/](review_packets/).
